Clinical Trial Update: A P3 Comparator Trial in Community Acquired Bacterial Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 comparator trial for community-acquired pneumonia sponsored by Durata Therapeutics (an Allergan affiliate) was withdrawn, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: Durata Therapeutics Inc., an affiliate of Allergan plc | Conditions: Community Acquired Pneumonia | Phase 3 | Status: WITHDRAWN